The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
Key Takeaways and Learnings Representation is so much more than just showing up. Performative inclusion weakens trust and risks perpetuating dispariti...
Key Takeaways and Learnings Traditional clinical trial recruitment often overlooks the cultural context, leading to underrepresentation and mistrust. ...
Key Takeaways and Learnings Authentic partnerships extend beyond individual studies and require long-term relationship building. Community expertise m...
Key Takeaways and Learnings Exclusionary and short-term research practices cost the pharmaceutical industry billions. Community-focused solutions make...
Key Takeaways and Learnings Decentralized clinical trials offer flexibility, but must be designed with intentional equity strategies to avoid widening...
Key Takeaways and Learnings Establishing inclusive research participation helps edify a healthier future for everyone. Key elements of thoughtful desi...
When I joined Acclinate, one phrase from our co-founder, Tiffany Whitlow, immediately took root in both my product mind and my heart: “We can only mov...
Key Takeaways and Learnings Traditional site selection criteria can perpetuate disparities. CROs must follow five key equity-focused strategies for su...
Key Takeaways and Learnings AI alone can’t build trust with underrepresented communities. It requires cultural insight, lived experience, and ongoing ...
